GENG Su-xia, DU Xin. Research Advances of Targeted Immune Checkpoint Therapy for Hematologic Tumor in 2020[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 45-49. DOI: 10.12019/j.issn.1671-5144.2021.01.012
|
Citation:
|
GENG Su-xia, DU Xin. Research Advances of Targeted Immune Checkpoint Therapy for Hematologic Tumor in 2020[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 45-49. DOI: 10.12019/j.issn.1671-5144.2021.01.012
|
GENG Su-xia, DU Xin. Research Advances of Targeted Immune Checkpoint Therapy for Hematologic Tumor in 2020[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 45-49. DOI: 10.12019/j.issn.1671-5144.2021.01.012
|
Citation:
|
GENG Su-xia, DU Xin. Research Advances of Targeted Immune Checkpoint Therapy for Hematologic Tumor in 2020[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 45-49. DOI: 10.12019/j.issn.1671-5144.2021.01.012
|
DownLoad: